DK
Therapeutic Areas
Kintor Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| KX-826 | Androgenetic Alopecia (AGA) | Phase 3 |
| GT20029 | Acne and AGA | Phase 2 |
| GT90001 | Multiple Cancers | Phase 2 |
| Pyrilutamide | Acne | Phase 2 |
| GT1709 | Acute Myeloid Leukemia | Phase 1 |
| Hedgehog Inhibitor | Basal-cell Carcinoma | IND Cleared |